PYREXIA is the #7 most commonly reported adverse reaction for ENOXAPARIN SODIUM, manufactured by Sanofi-Aventis U.S. LLC. There are 2,057 FDA adverse event reports linking ENOXAPARIN SODIUM to PYREXIA. This represents approximately 2.1% of all 96,320 adverse event reports for this drug.
Patients taking ENOXAPARIN SODIUM who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA2,057 of 96,320 reports
PYREXIA is a less commonly reported adverse event for ENOXAPARIN SODIUM, but still significant enough to appear in the safety profile.
Other Side Effects of ENOXAPARIN SODIUM
In addition to pyrexia, the following adverse reactions have been reported for ENOXAPARIN SODIUM:
PYREXIA has been reported as an adverse event in 2,057 FDA reports for ENOXAPARIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with ENOXAPARIN SODIUM?
PYREXIA accounts for approximately 2.1% of all adverse event reports for ENOXAPARIN SODIUM, making it a notable side effect.
What should I do if I experience PYREXIA while taking ENOXAPARIN SODIUM?
If you experience pyrexia while taking ENOXAPARIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.